Literature DB >> 27241105

Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.

Leora Witkowski1, Catherine Goudie2, William D Foulkes1, W Glenn McCluggage3.   

Abstract

Small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is a highly malignant and aggressive tumor and is the most common undifferentiated ovarian malignancy to occur in women younger than 40. SCCOHT is characterized by deleterious germline or somatic mutations in SMARCA4. Given the striking morphologic and molecular similarities between SCCOHT and atypical teratoid/malignant rhabdoid tumor, we propose this should be reflected in a nomenclature change and that SCCOHT be renamed malignant rhabdoid tumor of the ovary. SMARCA4 (BRG1) immunohistochemistry is useful in diagnosis because there is loss of nuclear immunoreactivity in SCCOHT but retention of staining in mimics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; Molecular genetics; Mutation; Ovary; SMARCA4; Small cell carcinoma of hypercalcemic type

Mesh:

Substances:

Year:  2016        PMID: 27241105     DOI: 10.1016/j.path.2016.01.005

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  10 in total

Review 1.  Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.

Authors:  Till Holsten; Susanne Bens; Florian Oyen; Karolina Nemes; Martin Hasselblatt; Uwe Kordes; Reiner Siebert; Michael C Frühwald; Reinhard Schneppenheim; Ulrich Schüller
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

Review 2.  Pathology of Neuroendocrine Tumours of the Female Genital Tract.

Authors:  Brooke E Howitt; Paul Kelly; W Glenn McCluggage
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

Review 3.  SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy.

Authors:  Kristina Mardinian; Jacob J Adashek; Gregory P Botta; Shumei Kato; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2021-10-12       Impact factor: 6.009

4.  In Vitro Effects of Mitochondria-Targeted Antioxidants in a Small-Cell Carcinoma of the Ovary of Hypercalcemic Type and in Type 1 and Type 2 Endometrial Cancer.

Authors:  Mariana Castelôa; Beatriz Moreira-Pinto; Sofia Benfeito; Fernanda Borges; Bruno M Fonseca; Irene Rebelo
Journal:  Biomedicines       Date:  2022-03-29

5.  Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.

Authors:  Marjorie P David; Rajkumar Venkatramani; Dolores H Lopez-Terrada; Angshumoy Roy; Ninad Patil; Kevin E Fisher
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-10-01

6.  Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.

Authors:  Angela Bellini; Nadia Bessoltane-Bentahar; Jaydutt Bhalshankar; Nathalie Clement; Virginie Raynal; Sylvain Baulande; Virginie Bernard; Adrien Danzon; Mathieu Chicard; Léo Colmet-Daage; Gaelle Pierron; Laura Le Roux; Julien M Planchon; Valérie Combaret; Eve Lapouble; Nadège Corradini; Estelle Thebaud; Marion Gambart; Dominique Valteau-Couanet; Jean Michon; Caroline Louis-Brennetot; Isabelle Janoueix-Lerosey; Anne-Sophie Defachelles; Franck Bourdeaut; Olivier Delattre; Gudrun Schleiermacher
Journal:  Int J Cancer       Date:  2019-05-31       Impact factor: 7.396

7.  Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature.

Authors:  Natacha Phoolcharoen; Terri Woodard; Deepthi James; Dina Patel; Sarah Roder; Deborah Holman; Mila Salcedo; Michael Frumovitz; David Gershenson; Kathleen Schmeler
Journal:  Gynecol Oncol Rep       Date:  2020-04-28

8.  Primary neuroendocrine tumors of the ovary: Management and outcomes.

Authors:  Li Pang; Zhiqiang Guo
Journal:  Cancer Med       Date:  2021-11-12       Impact factor: 4.452

Review 9.  Rare Hereditary Gynecological Cancer Syndromes.

Authors:  Takafumi Watanabe; Shu Soeda; Yuta Endo; Chikako Okabe; Tetsu Sato; Norihito Kamo; Makiko Ueda; Manabu Kojima; Shigenori Furukawa; Hidekazu Nishigori; Toshifumi Takahashi; Keiya Fujimori
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

Review 10.  Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.

Authors:  Marc Tischkowitz; Sidong Huang; Susana Banerjee; Jennifer Hague; William P D Hendricks; David G Huntsman; Jessica D Lang; Krystal A Orlando; Amit M Oza; Patricia Pautier; Isabelle Ray-Coquard; Jeffrey M Trent; Michael Witcher; Leora Witkowski; W Glenn McCluggage; Douglas A Levine; William D Foulkes; Bernard E Weissman
Journal:  Clin Cancer Res       Date:  2020-03-10       Impact factor: 13.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.